Skip to main content
SpringerLink
Log in

Comparison of technetium-99m MAG3 kit formulations in Europe and the USA

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hung JC. Comparison of technetium-99m MAG3 kit formulations in Europe and the USA. Eur J Nucl Med 1992; 19:990–992.

    Google Scholar 

  2. Taylor A Jr, Ziffer JA, Eshima D. Comparison of Tc-99m MAG3 and Tc-99m DTPA in renal transplant patients with impaired renal function. Clin Nucl Med 1990; 15:371–378.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radioisotopes Hôpital Saint-Pierre and AZ VUB, Brussels, Belgium

    A. Piepsz

Authors
  1. A. Piepsz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piepsz, A. Comparison of technetium-99m MAG3 kit formulations in Europe and the USA. Eur J Nucl Med 20, 361 (1993). https://doi.org/10.1007/BF00169816

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00169816

Keywords

Search

Navigation